UQ researchers have been awarded almost $1 million through the Australia-India Strategic Research Fund (AISRF) to combat the threat of antimicrobial resistance to human health.
Led by Professor Mark Blaskovich from the Institute for Molecular Bioscience, the project will combine research from UQ and AbGenics Life Sciences in India to support the development of new drugs and diagnostics to address this global challenge.
UQ researchers will characterise antibodies developed by AbGenics and create derivatives with enhanced abilities to detect and kill bacteria.
The AISRF supports collaboration between Australia and India's leading universities, research institutions and the end users of scientific innovation.
Active commuters less likely to suffer from heart disease and cancer, new research shows